| Emile Farhan |
Emile Farhan's career history includes current and former positions in the pharmaceutical industry. Currently, Emile is the Senior VP-Technical Operations & Quality Assurance at AVEO Pharmaceuticals, Inc. Previously, Emile held positions as the Director-Pharmaceutical Development at MGI PHARMA, Inc. from 2007 to 2008, Senior Director-Technical Operations at Veranova LP from 2000 to 2006, Senior Director-Product Development at Mersana Therapeutics, Inc., and Head-CMC Global Operations Coordination at Eisai Co., Ltd. from 2008 to 2011. Emile obtained a doctorate degree from Brandeis University and a graduate degree from the University of Massachusetts. |
| Michael Ferraresso |
Michael Ferraresso is currently the Chief Commercial Officer at AVEO Pharmaceuticals, Inc. He previously worked as the Vice President-Commercial at Infinity Pharmaceuticals, Inc. from 2013 to 2017. In 2017, he also briefly served as the Vice President-Commercial Operations at Verastem, Inc. Mr. Ferraresso completed his undergraduate degree at Assumption College. |
| Matthew Coulter |
Matthew Coulter is currently working as the Vice President of Information Technology at AVEO Pharmaceuticals, Inc. He completed his undergraduate degree at Babson College. |
| Stefanie Solomon |
Stefanie Solomon is currently the Head-Compliance at AVEO Pharmaceuticals, Inc. Previously, she worked as a Member-FDA Regulatory Law Practice at Hogan Lovells US LLP. She completed her undergraduate degree at Duke University and her graduate degree at Harvard Law School. |
| Jebediah Ledell |
Jebediah Ledell is currently the Chief Operating Officer at AVEO Pharmaceuticals, Inc. and Enzyvant, Inc. He previously held the same position at Compass Therapeutics LLC and Horizon Discovery Group Ltd. He was also the Head-US Operations at CombinatoRx, Inc. from 2004 to 2014. Mr. Ledell received his undergraduate degree from Worcester Polytechnic Institute. |
| Brent Gardner |
Brent Gardner currently works as an Executive Director-Medical Affairs at AVEO Pharmaceuticals, Inc. |
| Jinchul Jeong |
Jinchul Jeong currently works as a Chief Financial Officer at AVEO Pharmaceuticals, Inc. |
| Martin Birkhofer |
Martin Birkhofer is Chief Medical Officer for AVEO Pharmaceuticals, Inc.
In the past he was Chief Medical Officer of NuCana Plc, Chief Medical Officer for inVentiv Health Clinical, Inc. and Chief Medical Officer & Senior Vice President of Taiho Oncology, Inc.
Dr. Birkhofer received a doctorate from New York Medical College. |
| Michael Smith |
Michael Smith currently works as the Head of Compliance and Regulatory Counsel at AVEO Pharmaceuticals, Inc. |
| Michael P. Bailey |
Michael P. Bailey's current job(s) include serving as the President & Chief Executive Officer at AVEO Pharmaceuticals, Inc. since 2010 and as the Chairman at IMV, Inc. since 2020. Mr. Bailey's former job(s) include being a Member-Global Commercial Partnership Teams at Genentech, Inc. and serving as the Senior Vice President-Commercial Operations at ImClone LLC from 1999 to 2008. Additionally, he was the Chief Commercial Officer & Senior Vice President at Synta Pharmaceuticals Corp. from 2008 to 2010. In terms of education, Mr. Bailey completed his undergraduate degree at St. Lawrence University and obtained an MBA from Mendoza College of Business. |
| Corinne D. Epperly |
Corinne D. Epperly is a professional with experience in various firms. She has worked as a Director at IN8bio, Inc. since 2023. Previously, she worked as an Independent Director at AVEO Pharmaceuticals, Inc. from 2021 to 2023, a Research Analyst at Goldman Sachs International in 2010, the Chief Operating Officer at Vascular Biogenics Ltd. from 2017 to 2018, the Senior Vice President-Strategy & Operations at Iovance Biotherapeutics, Inc. from 2019 to 2020, and the Chief Operating Officer at Cargo Therapeutics, Inc. from 2021 to 2023. Dr. Epperly received her undergraduate degree from the University of Virginia and her graduate and doctorate degrees from The University of North Carolina at Charlotte. |
